相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Wnt3a signaling within bone inhibits multiple myeloma bone disease and tumor growth
Ya-Wei Qiang et al.
BLOOD (2008)
Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma
Ya-Wei Qiang et al.
BLOOD (2008)
Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo
Claire M. Edwards et al.
BLOOD (2008)
Expression of decorin, a small leucine-rich proteoglycan, as a prognostic factor in soft tissue tumors
Akihiko Matsumine et al.
JOURNAL OF SURGICAL ONCOLOGY (2007)
Skeletal remodeling in health and disease
Mone Zaidi
NATURE MEDICINE (2007)
The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patients
Nicola Giuliani et al.
BLOOD (2007)
Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo
Shmuel Yaccoby et al.
BLOOD (2007)
Type IV collagen-derived angiogenesis inhibitors
Thomas M. Mundel et al.
MICROVASCULAR RESEARCH (2007)
Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-κB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma
Evangelos Terpos et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
The low density lipoprotein receptor-related protein functions as an Endocytic receptor for decorin
Enrique Brandan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation
Daniela G. Seidler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Bortezomib increases osteoblast activity in myeloma patients irrespective of response to treatment
Ulrike Heider et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2006)
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
Chen Zhao et al.
CELL METABOLISM (2006)
The role of the bone microenvironment in the pathophysiology and therapeutic management of multiple myeloma: Interplay of growth factors, their receptors and stromal interactions
Constantine S. Mitsiades et al.
EUROPEAN JOURNAL OF CANCER (2006)
A role for decorin in cutaneous wound healing and angiogenesis
Hannu Jarvelainen et al.
WOUND REPAIR AND REGENERATION (2006)
A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: A potential role in the development of lytic bone disease and tumor progression in multiple myeloma
William G. Gunn et al.
STEM CELLS (2006)
Fibroblast activation protein (FAP) is upregulated in myelomatous bone and supports myeloma cell survival
Y Ge et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
The phenotypic plasticity of myeloma plasma cells as expressed by dedifferentiation into an immature, resilient, and apoptosis-resistant phenotype
S Yaccoby
CLINICAL CANCER RESEARCH (2005)
Response to bortezomib is associated to osteoblastic activation in patients with multiple myeloma
M Zangari et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis
JX Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Fibulins and cancer: friend or foe?
WM Gallagher et al.
TRENDS IN MOLECULAR MEDICINE (2005)
Expression of EGF-family receptors and amphiregulin in multiple myeloma.: Amphiregulin is a growth factor for myeloma cells
K Mahtouk et al.
ONCOGENE (2005)
Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation
DA Glass et al.
DEVELOPMENTAL CELL (2005)
Decorin, a novel player in the insulin-like growth factor system
E Schönherr et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Development of cellular models for ribosomal protein s19 (RPS19)-deficient Diamond-Blackfan anemia using inducible expression of siRNA against RPS19
K Miyake et al.
MOLECULAR THERAPY (2005)
Decorin prevents metastatic spreading of breast cancer
CC Reed et al.
ONCOGENE (2005)
Ex vivo transfer of the decorin gene into rat glomerulus via a mesangial cell vector suppressed extracellular matrix accumulation in experimental glomerulonephritis
HJ Wang et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2005)
Bone morphogenetic protein-5,-6 and-7 inhibit growth and induce apoptosis in human myeloma cells
TB Ro et al.
ONCOGENE (2004)
Cancer and the microenvironment: Myeloma-osteoclast interactions as a model
S Yaccoby et al.
CANCER RESEARCH (2004)
An inhibitor of the EGF receptor family blocks myeloma cell growth factor activity of HB-EGF and potentiates dexamethasone or anti-IL-6 antibody-induced apoptosis
K Mahtouk et al.
BLOOD (2004)
Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion
M Abe et al.
BLOOD (2004)
Cleavage of lumican by membrane-type matrix metalloproteinase-1 abrogates this proteoglycan-mediated suppression of tumor cell colony formation in soft agar
YY Li et al.
CANCER RESEARCH (2004)
Decorin inhibition of PDGF-stimulated vascular smooth muscle cell function - Potential mechanism for inhibition of intimal hyperplasia after balloon angioplasty
N Nili et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
A phase 2 study of bortezomib in relapsed, refractory myeloma
PG Richardson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Phenotype discovery by gene expression profiling: Mapping of biological processes linked to BMP-2-mediated osteoblast differentiation
E Balint et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Tumour necrosis factor-α interacts with biglycan and decorin
E Tufvesson et al.
FEBS LETTERS (2002)
Mice deficient in small leucine-rich proteoglycans:: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases
L Ameye et al.
GLYCOBIOLOGY (2002)
Decorin suppresses tumor cell-mediated angiogenesis
DS Grant et al.
ONCOGENE (2002)
Suppression of tumorigenicity by adenovirus-mediated gene transfer of decorin
CC Reed et al.
ONCOGENE (2002)
Bone morphogenetic protein (BMP)-2 induces apoptosis in human myeloma cells
C Kawamura et al.
LEUKEMIA & LYMPHOMA (2002)
Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells
FH Zhan et al.
BLOOD (2002)
Decorin inhibits endothelial migration and tube-like structure formation: Role of thrombospondin-1
CD Davies et al.
MICROVASCULAR RESEARCH (2001)
Binding of tenascin-X to decorin
F Elefteriou et al.
FEBS LETTERS (2001)
Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells
Ö Hjertner et al.
BLOOD (2001)
An anti-oncogenic role for decorin - Down-regulation of ErbB2 leads to growth suppression and cytodifferentiation of mammary carcinoma cells
M Santra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Sustained down-regulation of the epidermal growth factor receptor by decorin -: A mechanism for controlling tumor growth in vivo
G Csordás et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
